Raymond James says this satellite stock can jump 40% and could even double
The stock could rally up to 137% in a bull case, according to Raymond James.
Sage Therapeutics stock plunges more than 50% after FDA denies wider use of postpartum depression drug
The FDA approved the pill zuranolone, developed by Sage and Biogen, for postpartum depression but declined to approve it for major depressive disorder.
54 million Americans have been in credit card debt for at least a year. Here are the best payoff strategies
More cardholders are carrying more credit card debt than ever before, and, on top of that, they’re paying record high interest rates.
Wells Fargo upgrades DraftKings, says growth momentum will continue
Analyst Daniel Politzer upgraded shares to overweight from equal weight.
Guggenheim is bullish on this cybersecurity stock despite a recent sell-off
Guggenheim said it believes Fortinet remains a high-quality tech stock despite Friday’s dramatic sell-off.
‘Barbenheimer’ can boost Cinemark shares more than 35% from here, Morgan Stanley says
Despite the overhang of the Hollywood labor strikes, “a significant bull case remains” for Cinemark, according to Morgan Stanley.
UBS upgrades this kidney treatment stock, says it could rally 30%
The firm upgraded shares to buy and raised its price target to a Street high of $142, citing an upcoming inflection in treatment growth.
‘Of course he lost’: Ron DeSantis rejects Trump’s 2020 election claims
In an exclusive interview with NBC News, the Florida governor made his most definitive comments that Trump did not win in 2020. “Joe Biden’s the president,” he said.
Trump lawyer says Pence will be star witness for defense, while Pence says Trump team asked him to reject votes ‘outright’
Mike Pence says Trump team asked him to reject votes ‘outright’
Trump says he’ll seek a new judge in election case
Trump on Sunday called for recusal of the judge presiding over the case that alleges he illegally conspired to overturn his election loss in 2020.